Jurisprudence

Depuis 2004, date d'entrée en vigueur du premier Code mondial antidopage (le Code), de nombreuses décisions ont été rendues en application des règles du Code par le Tribunal arbitral du sport (TAS), ainsi que par d'autres instances internes des fédérations internationales et des organisations nationales antidopage. Dans le cadre de sa responsabilité du contrôle du respect du Code par ses signataires, l'AMA dispose d'un droit d'appel contre toute décision rendue en vertu du Code.

Le tableau ci-dessous présente une sélection de sentences du TAS visant à fournir aux parties prenantes des ressources et des orientations pertinentes. Pour consulter davantage de sentences du TAS, veuillez vous référer à la base de données de jurisprudence du TAS et au site web du TAS (pour les décisions récentes).

Date Reference ADRV Substance Keywords Outcome
30/Sep/25 CAS 2024/A/10988 2.1 Ostarine DNA Testing, Intent, NFN, NSFN, Origin Appeal upheld - 4-year POI
12/Sep/25 CAS 2024/A/10800 & 10802 2.1 Trenbolone Intent, Meat contamination, Origin Appeal partially upheld – 4-year POI
22/Jul/25 CAS 2024/A/10647 2.1 Chlortalidone NFN, NSFN, Origin Appeal upheld – 2-year POI
30/Apr/25 CAS 2024/A/10872 2.1 Clenbuterol ATF, Meat contamination Appeal upheld - case referred to NADO
20/Feb/25 CAS 2021/A/8343 2.3 - Evasion Appeal upheld – 4-year POI
27/Jan/25 CAS 2023/A/10045 2.5 - Exceptional Circumstances, Tampering Appeal upheld – 4-year POI
27/Aug/24 CAS 2023/A/9550, 9586 & 9607 2.2 - ABP, Proportionnality Appeal upheld - 4-year POI
29/Jan/24 CAS 2023/A/9451, 9455 & 9456 2.1 Trimetazidine Intent, Origin, Protected Person Appeal upheld – 4-year POI
28/Nov/23 CAS 2021/A/8126 & 8152 2.1 Dehydrochloromethyltestosterone  Disqualification, Intent, LIMS, Meat contamination Appeal partially upheld – 4-year POI
31/Oct/23 TAS 2022/A/9083 2.1 Tuaminoheptane NSFN, Medication Appeal partially upheld – 14-month POI
29/Sep/23 CAS 2023/A/9525 2.1 Furosemide Intent, Medication Appeal upheld – 4-year POI
5/Sep/23 CAS 2022/A/8809 2.4 - Whereabouts Failures Appeal upheld – 2-year POI
16/May/23 CAS 2021/A/8529 2.4 - Whereabouts Failures Appeal upheld – 20-month POI
31/Mar/23 CAS 2021/A/8458 2.1 Drostanolone Intent, Medication Appeal upheld – 4-year POI
9/Jun/22 CAS 2021/A/7838 2.2 Metenolone, Trenbolone Aggravating Circumstances, Disqualification, LIMS Appeal upheld – 4-year POI
16/Sep/21 CAS 2020/A/7579 & 7580 2.1 Ligandrol Intent, Origin Appeal dismissed – 2-year POI
30/Jun/21 CAS 2020/A/7526 & 7559 2.4 - Whereabouts Failures Appeal partially upheld – 2-year POI
22/Jun/21 CAS 2019/A/6148 2.3, 2.5 - Departure from ISTI, Refusal, Tampering Appeal upheld – 4-year-and-three-month POI
10/Nov/20 CAS 2020/A/6978 & 7068 2.1 Drostanolone Intent, Meat Contamination, Origin Appeal upheld – 4-year POI
4/Aug/20 CAS 2019/A/6226 2.2   ABP Appeal upheld – 4-year POI
27/Jan/20 CAS 2019/A/6112 2.1 Furosemide Departure from ISTI, Origin Appeal upheld – 2-year POI
30/Jul/18 CAS 2018/A/5546 & 5571 2.1 Cocaine NSFN, Proportionnality Appeal partially upheld – 14-month POI
24/Jul/17 CAS 2017/A/5000 2.1 Stanozolol Substantial Assistance Appeal dismissed – 8-year POI, 18 months of which are suspended
19/Jan/17 CAS 2016/A/4609 2.1 Nandrolone, Testosterone Intent, Medication Appeal upheld – 4-year POI